Korro Bio, Inc. logo KRRO - Korro Bio, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 10
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $19.57 DETAILS
HIGH: $30.00
LOW: $10.00
MEDIAN: $22.00
CONSENSUS: $19.57
UPSIDE: 68.56%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue 6.4 2.3 0 0 14.1 37.0 28.9 0 0
Cost of Revenue 4.3 0 0 0 3.8 1.6 16.8 0.7 0.5
Gross Profit 2.1 2.3 0 0 10.2 35.4 12.1 (0.7) (0.5)
Operating Expenses
R&D Expenses 65.6 63.6 57.2 42.2 59.3 36.7 18.3 11.6 11.8
SG&A Expenses 28.2 30.5 36.5 16.8 34.9 26.3 14.5 6.7 4.0
Other Expenses (4.3) 0 (9.3) 0 0 0 0 0 0
Operating Expenses 89.5 94.2 84.5 59.0 94.3 63.0 32.8 18.3 15.8
Operating Income
Operating Income (87.3) (91.9) (84.5) (59.0) (84.0) (27.6) (20.7) (18.9) (16.3)
Interest Expense 0 0 0 0.1 0.8 0 0 0.1 0.2
Interest Income 0 0 0 0.9 0.4 1.0 1.8 0 0
Profitability
EBITDA (83.1) (88.3) (80.9) (56.5) (80.1) (24.9) (17.9) (18.4) (19.5)
EBIT (87.3) (91.9) (84.5) (59.0) (83.9) (26.5) (18.7) (19.1) (20.1)
Income Before Tax (116.6) (83.4) (81.1) (58.0) (84.7) (26.5) (18.7) (19.2) (20.2)
Income Tax Expense 0.6 0.1 0.0 0.0 0.0 0.0 0 0 0
Net Income (117.3) (83.6) (81.2) (58.0) (84.7) (26.5) (18.7) (19.2) (20.2)
Per Share Data
EPS (Basic) -12.48 -9.37 -53.09 -227.58 -4.94 -41.10 -30.39 -30.57 -32.27
EPS (Diluted) -12.48 -9.37 -53.08 -227.42 -4.94 -41.10 -30.39 -30.57 -32.27
Shares Outstanding 9.4 8.9 1.5 0.3 4.4 0.6 0.6 0.6 0.6
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017
Current Assets
Cash & Cash Equivalents 21.8 55.6 166.2 36.9 79.6 220.3 200.2 42.2 17.9
Short-Term Investments 53.3 70.5 0 18.9 51.1 0 17.2 0 0
Net Receivables 1.0 1.7 0 0 0.1 0.3 0.8 0.2 0
Inventory 0 0 0 0 0 0 0 0 0
Other Current Assets 6.2 3.7 3.6 (0.4) 1.0 1.8 1 0.6 0.0
Total Current Assets 82.4 131.5 172.7 57.1 134.7 225.1 221.4 42.9 18.0
Non-Current Assets
Property, Plant & Equipment 16.2 51.5 42.8 11.9 36.9 37.8 1.8 1.5 1.7
Goodwill 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 37.0 0 4.5 13.4 1.8 0 0 0
Other Non-Current Assets 14.9 6.2 6.1 0.2 0.3 0 0.1 0.1 0.1
Total Non-Current Assets 31.1 94.7 48.9 16.7 50.6 39.7 1.9 1.6 1.8
Total Assets 113.5 226.2 221.7 73.7 185.4 264.7 223.2 44.5 19.8
Current Liabilities
Account Payables 1.7 4.0 7.3 2.6 2.7 5.5 1.2 1.9 1.0
Short-Term Debt 2.7 0 0 2.9 2.6 0.4 0 0 0
Deferred Revenue 7.8 3.5 0 0 0 14.1 48.2 0 0
Other Current Liabilities (0.2) 4.1 0.4 0.6 1.7 1.6 3.4 0.9 0.5
Total Current Liabilities 11.9 15.0 19.5 8.7 11.4 26.6 52.8 3.8 2.2
Non-Current Liabilities
Long-Term Debt 0 0 0 163.9 14.2 15 0 84.9 46.7
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 1.5 1.5 1.1 0 0.1 0 0.2 0.3 0.5
Total Non-Current Liabilities 50.1 50.9 32.3 164.1 43.1 45.6 3.1 85.3 47.2
Total Liabilities 62.1 65.8 51.8 172.8 54.5 72.2 55.9 89.1 49.4
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (383.8) (266.6) (183.0) (101.8) (180.1) (95.4) (68.9) (49.1) (29.9)
Accumulated Other Comprehensive Income 0.2 0.3 0 (0.0) (0.1) 0.0 0.1 0 0
Total Stockholders' Equity 51.4 160.4 169.9 (99.0) 130.8 192.5 167.4 (48.3) (29.6)
Total Liabilities & Equity 113.5 226.2 221.7 73.7 185.4 264.7 223.2 44.5 19.8
Debt Metrics
Total Debt 43.5 44.8 33.2 167.0 45.6 46.0 0 84.9 46.7
Net Debt 21.7 (10.9) (132.9) 130.1 (34.0) (174.3) (200.2) 42.7 28.8
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017
Operating Activities
Net Income (117.3) (83.6) (81.2) (58.0) (22.0) (10.2) (18.7) (19.2) (20.2)
Depreciation & Amortization 3.8 3.6 3.6 2.5 1.6 1.6 0.8 0.7 0.5
Stock-Based Compensation 7.7 4.5 2.4 1.1 0.8 0 0 0 0
Change in Working Capital (4.4) 13.6 4.3 (0.6) 0.9 (30.2) 48.6 0.8 0.3
Other Non-Cash Items 31.7 1.9 3.6 1.5 (13.4) (6.3) 3.5 2.0 5.9
Operating Cash Flow (78.6) (60.1) (67.3) (53.6) (32.1) (45.2) 34.2 (17.0) (14.6)
Investing Activities
Capital Expenditure (0.5) (17.9) (7.8) (5.2) (4.4) (6.7) (1.1) (0.4) (1.9)
Acquisitions 0 0 0 0 0 0 0 3.8 0
Purchases of Investments (26.2) (146.3) 0 (37.2) (35.1) (26.3) (282.6) 0 0
Sales/Maturities of Investments 70.7 40.9 19 53.5 0 43.4 265.4 0 0
Other Investing Activities 0 0 0 0 0.0 0 0 0 0
Investing Cash Flow 44.0 (123.3) 11.2 11.1 (39.5) 10.4 (18.3) 3.3 (1.9)
Financing Activities
Net Debt Issuance 0 0 0 0 0 15 0 5 0
Stock Repurchased 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 2.0 25.1 (0.0) (0.0) 0 0 0 0
Financing Cash Flow 0.7 69.4 187.8 0.0 115.9 56.7 142.0 37.9 28.0
Cash Position
Net Change in Cash (33.8) (114.1) 131.6 (42.6) 44.4 20.2 158.0 24.3 11.5
Cash at Beginning 59.0 173.1 41.5 84.0 39.7 200.2 42.2 17.9 6.4
Cash at End 25.2 59.0 173.1 41.5 84.0 220.3 200.2 42.2 17.9
Free Cash Flow (79.1) (78.0) (75.1) (58.9) (36.5) (51.9) 33.2 (17.5) (16.5)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017
Income Statement
Revenue 6.4 2.3 0 0 14.1 37.0 28.9 0 0
Gross Profit 2.1 2.3 0 0 10.2 35.4 12.1 (0.7) (0.5)
Operating Income (87.3) (91.9) (84.5) (59.0) (84.0) (27.6) (20.7) (18.9) (16.3)
Net Income (117.3) (83.6) (81.2) (58.0) (84.7) (26.5) (18.7) (19.2) (20.2)
EPS (Diluted) -12.48 -9.37 -53.08 -227.42 -4.94 -41.10 -30.39 -30.57 -32.27
Balance Sheet
Cash & Equivalents 21.8 55.6 166.2 36.9 79.6 220.3 200.2 42.2 17.9
Total Assets 113.5 226.2 221.7 73.7 185.4 264.7 223.2 44.5 19.8
Total Debt 43.5 44.8 33.2 167.0 45.6 46.0 0 84.9 46.7
Stockholders' Equity 51.4 160.4 169.9 (99.0) 130.8 192.5 167.4 (48.3) (29.6)
Cash Flow
Operating Cash Flow (78.6) (60.1) (67.3) (53.6) (32.1) (45.2) 34.2 (17.0) (14.6)
Capital Expenditure (0.5) (17.9) (7.8) (5.2) (4.4) (6.7) (1.1) (0.4) (1.9)
Free Cash Flow (79.1) (78.0) (75.1) (58.9) (36.5) (51.9) 33.2 (17.5) (16.5)